Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.19.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2019
Dec. 31, 2018
Assets    
Equity method investments $ 458,916 $ 471,044
Government receivables 463,715 497,464
Commercial receivables 453,828 447,196
Real estate 364,582 365,370
Investments 177,636 169,793
Cash and cash equivalents 62,091 21,418
Other assets 206,102 182,628
Total Assets 2,186,870 2,154,913
Liabilities:    
Accounts payable, accrued expenses and other 33,266 36,509
Deferred funding obligations 66,350 72,100
Credit facilities 283,381 258,592
Non-recourse debt (secured by assets of $1,041 million and $1,105 million, respectively) 814,662 834,738
Convertible notes 147,150 148,451
Total Liabilities 1,344,809 1,350,390
Stockholders’ Equity:    
Preferred stock, par value $0.01 per share, 50,000,000 shares authorized, no shares issued and outstanding 0 0
Common stock, par value $0.01 per share, 450,000,000 shares authorized, 62,875,638 and 60,510,086 shares issued and outstanding, respectively 629 605
Additional paid in capital 1,009,346 965,384
Accumulated deficit (170,953) (163,205)
Accumulated other comprehensive income (loss) (375) (1,684)
Non-controlling interest 3,414 3,423
Total Stockholders’ Equity 842,061 804,523
Total Liabilities and Stockholders’ Equity $ 2,186,870 $ 2,154,913